Skip to main content

Breadcrumb

  1. Home

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

The Jewel IDE Study

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about The Jewel IDE Study

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • …
  • Next page Next
  • Last page Last
Subscribe to